1
Clinical Trials associated with Recombinant human erythropoietin(China Resources Angde)A Phase Ⅱ Clinical Study on the Efficacy, Safety, Pharmacokinetics and Pharmacodynamics of Polyethylene Glycol Recombinant Human Erythropoietin Injection (CHO Cell) in Optimal Dose and Administration Regimen for Maintenance Therapy in Patients With Regular Dialysis Renal Anemia.
The purpose of the study is to explore the optimal dose and administration of the experimental drug, and to evaluate the safety and efficacy of the drug in patients with renal anemia. Patients with renal anemia on regular dialysis treatment are expected to be enrolled in this study.
100 Clinical Results associated with Recombinant human erythropoietin(China Resources Angde)
100 Translational Medicine associated with Recombinant human erythropoietin(China Resources Angde)
100 Patents (Medical) associated with Recombinant human erythropoietin(China Resources Angde)
100 Deals associated with Recombinant human erythropoietin(China Resources Angde)